Seagen (SGEN) Appoints David R. Epstein as CEO and Director
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Seagen's announcement likely confirms it will remain a standalone company - Raymond James
November 10, 2022 10:36 AM ESTRaymond James analyst Dane Leone told investors in a note Thursday that Seagen (NASDAQ: SGEN) announcing David Epstein as their new Chief Executive Officer and member of the board means it likely confirms that Seagen will remain a stand-alone entity.
Seagen shares are down more than 5% in early Thursday... More
Seagen (SGEN) Falls as CEO News Dashes Buyout Hopes
November 10, 2022 8:51 AM ESTSeagen (NASDAQ: SGEN) is down 3.3% in pre-open trading following news it named David R. Epstein as CEO, which is dashing M&A hopes. Merck (NYSE: MRK) was seen as a buyer of the company but an... More
